Application of CoLD-CoP to Detecting Competitively and Cooperatively Binding Ligands
-
Published:2024-09-09
Issue:9
Volume:14
Page:1136
-
ISSN:2218-273X
-
Container-title:Biomolecules
-
language:en
-
Short-container-title:Biomolecules
Author:
Patnala Shiva V.1ORCID, Robles Roberto1, Snyder David A.1ORCID
Affiliation:
1. Department of Chemistry, College of Science and Health, William Paterson University, 300 Pompton Road, Wayne, NJ 07470, USA
Abstract
NMR utilization in fragment-based drug discovery requires techniques to detect weakly binding fragments and to subsequently identify cooperatively binding fragments. Such cooperatively binding fragments can then be optimized or linked in order to develop viable drug candidates. Similarly, ligands or substrates that bind macromolecules (including enzymes) in competition with the endogenous ligand or substrate are valuable probes of macromolecular chemistry and function. The lengthy and costly process of identifying competitive or cooperative binding can be streamlined by coupling computational biochemistry and spectroscopy tools. The Clustering of Ligand Diffusion Coefficient Pairs (CoLD-CoP) method, previously developed by Snyder and co-workers, detects weakly binding ligands by analyzing pairs of diffusion spectra, obtained in the absence and the presence of a protein. We extended the CoLD-CoP method to analyze spectra pairs (each in the presence of a protein) with or without a critical ligand, to detect both competitive and cooperative binding.
Reference38 articles.
1. Fragment-Based Lead Discovery;Rees;Nat. Rev. Drug Discov.,2004 2. Austin, D., and Hayford, T. (2021). Research and Development in the Pharmaceutical Industry, Congressional Budget Office. 3. Current Perspectives in Fragment-Based Lead Discovery (FBLD);Lamoree;Essays Biochem.,2017 4. Emwas, A.-H., Szczepski, K., Poulson, B.G., Chandra, K., McKay, R.T., Dhahri, M., Alahmari, F., Jaremko, L., Lachowicz, J.I., and Jaremko, M. (2020). NMR as a “Gold Standard” Method in Drug Design and Discovery. Molecules, 25. 5. Kirsch, P., Hartman, A.M., Hirsch, A.K., and Empting, M. (2019). Concepts and Core Principles of Fragment-Based Drug Design. Molecules, 24.
|
|